Product Information
BREO ELLIPTA 50-25 MCG INHALER is a brand product labeled by GlaxoSmithKline LLC, priced at $6.4835 per EA under NDC 00173091610. Its NADAC has been published 110 times since May 22, 2024.
Strength
50; 25 ug/1; ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173091610
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
FLUTICASONE FUROATE; VILANTEROL TRIFENATATEApproval Type
New Drug (NDA)
FDA Application
NDA204275On Market Since
5/12/2023
Pharmacological Classes
Price Statistics
The NADAC for BREO ELLIPTA 50-25 MCG INHALER has been published 110 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.4835 per EA |
|---|---|
| All-time high | $6.5164 (Jun 12, 2024) |
| All-time low | $6.4835 (Jun 17, 2026) |
| 52-week high | $6.4974 |
| 52-week low | $6.4835 |
| Median price | $6.4980 |
| Average price | $6.4984 |
| Largest weekly change | -0.1% (Jun 19, 2024) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the fluticasone furoate and vilanterol trifenatate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BREO ELLIPTA 50-25 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for BREO ELLIPTA 50-25 MCG INHALER, manufactured by GlaxoSmithKline LLC, is $6.4835 per EA (NDC 00173091610), effective Jun 24, 2026.
How has the price of BREO ELLIPTA 50-25 MCG INHALER changed over time?
Over the history we have for it, the NADAC for BREO ELLIPTA 50-25 MCG INHALER has held within roughly two percent of its current level. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BREO ELLIPTA 50-25 MCG INHALER?
Since May 22, 2024, the NADAC for BREO ELLIPTA 50-25 MCG INHALER has ranged from a low of $6.4835 (Jun 17, 2026) to a high of $6.5164 (Jun 12, 2024), with a median of $6.4980 per EA.
Are there cheaper alternatives to BREO ELLIPTA 50-25 MCG INHALER?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BREO ELLIPTA 50-25 MCG INHALER, so no direct lower-cost alternative is listed.
Who manufactures BREO ELLIPTA 50-25 MCG INHALER?
BREO ELLIPTA 50-25 MCG INHALER (NDC 00173091610) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification